Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
824 participants
OBSERVATIONAL
2024-07-25
2025-01-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Palliative Outcome Evaluation Muenster I
NCT03286127
The Clinical Effect of Palliative Treatment on Patients With Terminal Cancer
NCT05683236
Palliative Care in General Practice: Cancer Patient/Carer Experience
NCT03243188
Examining Early Palliative Care in Newly Diagnosed Cancer Patients
NCT03712436
Virtual Versus In-Person Approaches
NCT07274904
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Provided informed consent to participate
* Completed the survey in either Arabic or English
Exclusion Criteria
* Incomplete survey responses (if applicable)
14 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Burjeel Medical City
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Humaid O. Al-Shamsi
Chief Executive Officer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Burjeel Cancer Institute
Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BH/REC/073/24
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.